Abstract-Local hemodynamic forces are well-known to modulate atherosclerotic evolution, which remains one of the largest cause of death worldwide. Percutaneous coronary interventions with stent implantation restores blood flow to the downstream myocardium and is only limited by stent failure caused by restenosis, stent thrombosis, or neoatherosclerosis. Cumulative evidence has shown that local hemodynamic forces affect restenosis and the platelet activation process, modulating the pathophysiological mechanisms that lead to stent failure. This article first covers the pathophysiological mechanisms through which wall shear stress regulates arterial disease formation/neointima proliferation and the role of shear rate on stent thrombosis. Subsequently, the article reviews the current evidence on (1) the implications of stent design on the local hemodynamic forces, and (2) how stent/scaffold expansion can influence local flow, thereby affecting the risk of adverse events. Visual Overview-An online visual overview is available for this article.
A dvances in stent technology, drug polymer biocompatibility, and design have improved the safety and efficacy of coronary stent devices. Despite these advances, restenosis and device thrombosis remain a major concern and are still affecting long-term clinical outcomes. 1 Randomized trials and clinical registries show that the rate of stent thrombosis is <1% after 1 year, and the restenosis rates remain at ≈5%. 2 Nevertheless, the cumulative incidences of these events in the long term still remain substantial. Hence, it is crucial to identify the causes of stent/scaffold failure and understand how the hemodynamic environment impacts clinical outcomes postpercutaneous coronary intervention (PCI). With current high-resolution intravascular imaging, geometrically accurate representation of patient-specific coronary anatomy can be reconstructed for blood flow simulation, enabling precise endothelial shear stress (ESS) maps to be generated ( Figure 1 ). Patient-specific biomechanical forces can then be quantified to investigate the pathophysiological implications of the flow patterns in stented/scaffolded segments and their role in neointimal hyperplasia and device thrombosis. 4 This article will first define the metrics of local hemodynamics and introduce the main pathophysiological mechanisms, followed by a summary on the evidence about the role of the local hemodynamics on stent thrombosis and restenosis.
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Metrics of Local Hemodynamics
Shear Rate Shear rate is defined as the local velocity gradient between adjacent blood flow streamlines ( Figure 2 ) and provides a quantitative representation of local flow disturbance. Shear rate is also one of the main regulators of platelet activation and thrombosis. 6, 7 In medium-to large-sized arteries, physiological shear rate falls within the range of 100 to 1000 s −1 . 8 . In silico and in vivo studies have shown that in stented/scaffolded segments, the rigid protruding and malapposed struts create flow obstructions that disrupt blood flow, resulting in flow separation and shear rates >2000 s −1 .
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Endothelial Shear Stress ESS is estimated by multiplying the shear rate at the wall surface with the viscosity of blood ( Figure 2 ) and represents the tangential frictional stress on the vessel wall imposed by the flowing blood. In vivo evaluations of ESS using computational fluid dynamic methods have shown that its distribution predicts atherosclerotic lesion development. [13] [14] [15] [16] [17] Low and oscillatory ESS is a known modulator of arterial wall physiology, specifically via impaired endothelial cell function where low ESS has been shown to regulate gene expression and vascular proinflammatory response through multiple mechanotransduction pathways.
Hemodynamics Impact on Disease Process Low ESS and Arterial Disease Development
The endothelium senses changes in ESS via several mechanotransduction processes that involve activation/release of signaling proteins in endothelial cells and smooth muscle cells, which in turn regulate vessel wall physiology. [20] [21] [22] [23] [24] [25] The type and magnitude of response are determined by the magnitude and direction of ESS. 26 Experimental studies have demonstrated that low ESS (<10 dynes/cm 2 ) causes misalignment of the endothelium 27, 28 and disruption of cell-cell junctions. [29] [30] [31] This increases the permeability of the endothelium to circulating lipids and inflammatory regulators. [32] [33] [34] In addition, low ESS decreases vasodilator, 25 fibrinolytics, 35 and antioxidants 36 and increases expression of cell adhesion molecules, 22 growth factors, 37 vasoconstrictors, 38 oxidative species, 39 proteolytic enzymes, 40 and acute inflammatory mediators. 41 This leads to endothelial dysfunction, vessel inflammation, and smooth muscle cells proliferation, contributing to plaque growth and arterial expansive remodeling. 14 The behavior of smooth muscle cells is regulated by the interaction with endothelial cells but also by mechanical forces, such as shear stress. ESS leads to the release of platelet-driven growth factor and transforming growth factor which causes smooth muscle cell proliferation and migration, subsequently resulting in neointimal hyperplasia and restenosis. 14, 26, 38 When there is no endothelium, Liu and Goldman 42 demonstrated that smooth muscle cell migration is significantly suppressed under laminar flow conditions compared with regions that are exposed to recirculating and unsteady flow.
Shear modification has been shown to modulate plaque progression and the degree of inflammation in animal models. 18, 43 Low and oscillating ESS has been reported to accelerate vulnerable atherosclerotic plaque formation. 18, 19 In a recent experimental study using intracoronary shear-modifying stents in hypercholesterolemic pigs, Pedrigi et al 44 reported an ≈3-fold increase in plaque burden distal to the shear-modifying stents compared with both proximal segment and the control arteries. Advanced coronary plaques were colocated mostly downstream of the shear-modifying stents, in regions of low ESS. 44 Although low ESS alone has been shown to increase plaque progression, a combination of low and oscillatory ESS is considered to be particularly atherogenic. Flow simulations on intravascular ultrasound-derived vessels of patients with coronary artery disease demonstrated that low and oscillatory ESS can cause plaques to evolve into a more vulnerable phenotype compared with low ESS only because of more inflammation and necrotic core progression. 45 The 
Low ESS and Restenosis Post-PCI
Studies have reported that there is also an inverse correlation between baseline ESS and neointimal thickness at followup (ie, low ESS increases neointimal proliferation). In the study conducted by Wentzel et al, 50 blood flow simulation was performed in segments implanted with bare metal stents (BMS). The ESS distribution was estimated on the reconstructed surfaces of stented vessel segments after implantation and at 6-month follow-up. An inverse association was found between baseline ESS and neointima formation at 6-month follow-up. 50 These findings were confirmed in several other studies. 3, 50, 52, 53, 58, 59 Papafaklis et al 53 investigated the implications of the local hemodynamic forces on neointimal response in BMS and first-generation drug-eluting stents (DES). The study reported an inverse correlation between ESS and neointima response in BMS while in DES vessels, wall response was shown to depend on the antiproliferative drug. Sirolimus seems to reduce the amount of positive cell cycle regulators and increase the amount of cell cycle inhibitors, leading to inhibited cell migration, proliferation, and desensitization of the cells to the effects of low ESS.
The PREDICTION study (Prediction of Progression of Coronary Artery Disease and Clinical Outcome Using Vascular Profiling of Shear Stress and Wall Morphology) was the largest ESS study investigating the implications of the local hemodynamic forces on the healing response after BMS and first-generation DES in vivo. The relationship between postprocedural ESS and neointimal in-stent hyperplasia was investigated by comparing the 3-dimensional reconstructed stented segments of 374 patients at baseline immediately after stent implantation and 6-to 10-month follow-up. 17, 57 The study demonstrated an inverse relationship between ESS and neointima response in BMS while in DES, the neointima tissue was too limited for assessment of the association between ESS and neointima tissue. 57 Bourantas et al 56 have also investigated the association between ESS and neointima proliferation using serial intravascular ultrasound imaging in 43 patients implanted with either BMS or biolimus-eluting stents at baseline and 13-month follow-up. Negative correlations were noted between ESS and neointima thickness in both groups. There was also a negative correlation between ESS and the percentage of neointimal necrotic core component (P=0.015) in BMS while the limited neointima formation impeded the evaluation of the effect of ESS on neointima characteristics in DES.
Optical coherence tomography-based reconstruction was used to assess the implications of the ESS on neointima response in 12 patients implanted with an everolimus-eluting bioresorbable vascular scaffold (BVS; Absorb BVS; Abbott Vascular, Santa Clara, CA). In this analysis, the optical coherence tomography data acquired at baseline and 1-year follow-up were used to model vessel geometry. 55 The authors showed that the protruding struts resulted in low ESS in the areas between the struts and high ESS at the top of the struts. A strong negative correlation was observed between baseline ESS and neointimal thickness at follow-up; and increased neointima proliferation was found in the areas between the struts where the ESS was. This resulted in a smoothening of the rugged luminal surface and a homogenization of the ESS at 2-year follow-up. 55 Recently, Torii et al 60 evaluated the implications of the local flow patterns on neoatherosclerotic lesion formation in 35 patients implanted with either BMS or DES. The patients were admitted with coronary events attributed to stent failure and had neoatherosclerotic lesions based on optical coherence tomography images. An inverse association was noted between ESS and the incidence and burden of lipid-rich neoatherosclerotic tissue (P<0.001). Segments exposed to low ESS (<1 Pa) were more likely to exhibit macrophage accumulations, thrombus, or neointima discontinuities compared with those exposed to normal or high ESS (P<0.001). These results indicate that local ESS also plays a role in the regulation of neoatherosclerosis lesion formation in stented segments 60 ( Figure 3 ). Shear rate seems to play an important role on vessel physiology and determines the concentration of platelets and adhesion proteins near the vessel wall. In segments exposed to high shear rate, red blood cells cause platelets displacement toward the vessel wall via a process called margination. The accumulation of platelets and adhesion proteins near the vessel wall creates a prothrombotic environment. [61] [62] [63] When adhesion proteins like Von Willebrand factor and fibrinogen come in contact with a thrombogenic surface (ie, ruptured plaques and stent struts), a clot cascade is triggered. Once the adhesion proteins attach to the thrombogenic surface, they stimulate activated platelets to bind to the surface. At high shear rates, the globular structure of the Von Willebrand factor elongates into a string structure, [64] [65] [66] [67] increasing the amount of platelet binding sites on the molecule. With high shear rates (≈10 000 s −1 ), Von Willebrand factor strings combine to form nets that further increase the amount of platelet binding sites by ≈10 000×. 66, 68 The attracted platelets are exposed to high ESS, which shortens their activation time. 69 As the thrombus grows, more Von Willebrand factor nets are formed which subsequently increase the number of bound platelets. This positive feedback loop results in thrombus formation. 
Stent-Induced Hemodynamic Changes
During PCI
In the BMS era, excessive neointimal proliferation was a major drawback that caused early restenosis. 70 With the introduction of DES, the occurrence of restenosis has been significantly reduced. However, in-stent thrombosis has remained an issue observed at both short-and long-term follow-up. It was reported that strut dimensions and the distance of the struts from the vessel wall affect stent thrombogenicity more than the presence of drug coatings. 11 Although stent thrombosis may have a relatively low incidence (0.6%-3.4%), 71 it is still the most feared complication after PCI because of the associated mortality risk for the patients. 72 Studies have revealed that the major causes of early stent thrombosis (<30 days) are largely because of stent underexpansion and malapposition while late stent thrombosis (>30 days) is found frequently with late remodeling, stent strut malapposition, and delayed endothelial coverage.
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Stent Design
Stent design has an impact on the flow dynamics in stented segments. Strut thickness, in particular, is a major factor affecting local shear rate and ESS post-PCI. Large strut thickness increases the amount of foreign material in the lumen and leads to flow disturbances, flow separation, and areas of recirculation zones, thereby increasing the risk of stent thrombosis. [9] [10] [11] [12] 55, 73 Models have shown that the maximal distance between the helical rings should be at least 6× the strut thickness to recover any laminar flow in the interstrut zones. 74 Smaller strut thickness can improve re-endothelialization and reduce peristrut inflammation and fibrin deposition. [75] [76] [77] In the BMS era, clinical studies have reported improved outcomes in patients implanted with thin strut stents. [78] [79] [80] [81] Flow separation distance was also found to be longer in nonstreamlined struts (rectangular) compared with streamlined struts (circular/ovoid). 82 Polymer coating is another essential part of stent design that can affect stent's thrombogenicity. Otsuka et al 83 observed in an ex vivo model that the fluoropolymer-coated Xience DES showed a significantly lower percentage of a thrombus-occupied areas compared with a DES with contemporary biodegradable coatings. Kolandaivelu et al 11 investigated the implications of stent design and drug coating on the incidence of stent thrombosis by deploying DES and BMS with identical design but different strut thickness in ex vivo perfusion models. Results indicated that DES with a biocompatible drug coating had a 0.65-fold lower thrombogenicity compared with BMS while thicker struts stents were 1.5× more thrombogenic than thin strut stents with the same design. 11 Current bioresorbable scaffolds (BRS) have thicker struts (≥150 µm) compared with second-generation metallic DES (≤100 µm). One of the most widely examined BRS is the Abbott Vascular's Absorb BVS, which is fabricated from a poly-L-lactic acid backbone. The Absorb BVS has a strut thickness of 156 µm and a width of 190 µm while the Xience DES has a total strut thickness of 89 µm. Because of the lower elastic modulus and tensile strength of the bioresorbable materials, thicker struts are often required in BRS to In scaffolded segment models, the ESS estimated by the fusion of IVUS and x-ray angiography differs from the ESS derived from the fusion of OCT and x-ray imaging. The correlation coefficient between ESS and neointima thickness is increased in OCT-based modeling comparing to IVUS-based reconstructions.
Bourantas et al A summary on patient studies that look the effect of shear stress on atherosclerosis and restenosis. Most atherosclerosis showed an inverse association between ESS and plaque or neointima burden. BES indicates biolimus eluting stents; BMS, bare metal stents; BRS, bioresorbable scaffolds; ESS, endothelial shear stress; IVUS, intravascular ultrasound; OCT, optical coherence tomography; and PCI, percutaneous coronary intervention. December 2017 achieve a radial force similar to that of conventional metallic platforms. [84] [85] [86] Studies have shown more extensive neointimal hyperplasia and late lumen loss in BRS compared with DES at shortterm follow-up. 85, [87] [88] [89] [90] [91] Large strut size and other factors, such as scaffold underexpansion, incomplete scaffolding, and the acidic environment during polymer dissolution, may play a role in causing late lumen loss in BRS device. It has been hypothesized that the large strut profile of current generation of BRS is harder to embed in the tissue, hence creating a larger obstacle for blood flow. 92 Computational flow simulations showed >50% increase in maximum shear rate values with protruding stent struts 10 compared with embedded struts. These flow patterns around indented struts are commonly associated with increased platelet adhesion 11, 93 and inflammatory response, 94 as well as reduced re-endothelialization.
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Under Expansion
Stent underexpansion is usually quantified by the postprocedural diameter stenosis in quantitative coronary angiography and intravascular imaging. This is done by measuring the minimum lumen area of the stent/scaffold segment and relative percentage area stenosis. Underexpansion can be caused by inappropriate lesion preparation and postdilatation of the implanted stent/scaffold with too small balloons or insufficient pressure, particularly in fibrotic or fibrocalcific lesion types. 98 Stent underexpansion leads to shear stress concentration on the edges of the stent struts and higher jet and shear rate in the underexpanded segment, which may increase the risk of stent thrombosis. 99 Stent underexpansion has been commonly associated with early stent thrombosis (>30 days). [100] [101] [102] Fujii et al 101 conducted an analysis on 15 patients admitted for stent thrombosis and compared them with 45 matched control patients with no stent thrombosis. The study showed that the stent cross-sectional area was significantly smaller in the stent thrombosis group than in the matched control patients (4.3±1.6 versus 6.2±1.9 mm 2 ). 101 Another study sought to compare the acute gain and late lumen loss between Absorb BVS and DES at 2-year followup. Thirty-three patients implanted with BVS and 26 patients implanted with the DES from the ABSORB B (ABSORB Clinical Investigation, Cohort B) and SPIRIT II (A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System) trials were examined. Analysis showed similar acute gain . Stent strut protrusion and thrombosis. Embedded struts disrupt blood flow the least out of the 3 scenarios and has the lowest area of recirculation and physiological levels of shear rate. Hence, activator proteins like vWF (Von Willebrand factor) are not activated, and platelet adhesion and aggregation remain at a minimum. Malapposed struts have regions of high shear rate both at the top and bottom of the strut and a larger surface area for adhesion proteins to bind to, creating a thrombogenic surface as compared with a protruding strut. At high shear rates, platelets are activated via the vWFbinding to glycoprotein (GP) lb and GP llb/llla receptors 13, 108 resulting in clot formation and potentially thrombosis formation. 6, 7 Top panels adapted from Koskinas et al 13 with permission. Copyright ©2012, Elsevier.
In a recent study, Foin et al 105 compared the acute expansion behavior of DES and Absorb BVS in an in vitro artery lesion model. Results showed that stent eccentricity at the minimum lumen area was lower in the BVS compared with Xience metallic stent when deployed at nominal pressure (BVS: 0.71±0.02 versus Xience: 0.81±0.02; P=0.004). These anatomic differences were associated with increased shear rate and increased recirculation zones at the downstream of the underexpanded segment. 105 Computational fluid dynamic models have also demonstrated that even at the same diameter stenosis, an eccentric lesion induces larger recirculation. Therefore, when the stent is not symmetrically expanded, intravascular imaging should be considered to assess the final result. 106 Scaffold underexpansion has been shown to be also a predictor of events in the Absorb BVS. Puricel et al 84 investigated the incidence, clinical and angiographic features, as well as the possible mechanisms of stent thrombosis in 1305 patients implanted with BVS. The study revealed that a low postprocedural minimum lumen diameter and low reference diameters were predictors of stent thrombosis. 84 The risk of stent thrombosis increased rapidly for minimum lumen diameter <2.4 mm for the 2.5-to 3.0-mm BVS and <2.8 mm for BVS that had a 3.5-mm diameter. 84 However, when aggressive lesion preparation and aggressive device postdilatation was implemented, scaffold thrombosis at 1-year follow-up fell from 3.3% to 1.0% (P=0.012), 84 suggesting that the implantation technique could be the key to reducing scaffold thrombosis in BVS. Figure 5 . Impact of strut thickness on blood flow profiles for model simulating case of well-apposed and malapposed drug-eluting stents (DES) and bioresorbable scaffolds (BRS) struts. A, Simulated blood flow streamlines (top) for the different cases of strut apposition: (1) apposed and (2) malapposed (with strut to wall distance=300 µm). Models are representative of a 3-mm diameter straight coronary artery flow with a parabolic upstream velocity profile and a peak velocity of 50 cm/s. The 2 strut thicknesses are considered to correspond to a total strut thickness (strut+coating) of 156 µm (Absorb BVS) and 97 µm (Xience DES). B, Corresponding shear rate profile in blood around stent strut simulated for each case (bottom) shows that flow disturbances and high shear rates (red) are increased primarily in thicker and malapposed struts. Reprinted from Foin et al 99 with permission. Copyright ©2015, Europa Digital & Publishing.
Malapposition
Malapposition, also known as incomplete stent apposition (ISA), can affect local flow and shear profile in the stented vessel. A stent strut is considered malapposed when is not in contact with the vessel wall. Malapposed stent struts disrupt the laminar flow and can generate regions of high shear rate (Figures 4 and 5) 10,11,13 which are known to affect the risk of stent thrombosis. 11, 77, 107 In an in vitro experiment, Kolandaivelu et al 11 showed that malapposed BMS showed a 1.5-fold increase in thrombogenicity compared with wellapposed stents (P=0.001).
Malapposition also reduces stent strut coverage. A recent study analyzed the impact of baseline strut-vessel wall ISA distance on strut coverage at follow-up. As ISA increases from <100 µm to 100 to 300 µm and finally to >300 µm, the percentage of uncovered struts at follow-up increased from 0% to 6.1% and 15.7%, respectively. 10 Recently, reports have pointed to ISA as a possible mechanism leading to scaffold thrombosis in BRS. [109] [110] [111] [112] In one study, Gomez-Lara et al showed that malapposed BRS struts are more frequently uncovered compared with apposed struts (29% of ISA struts versus 1% of apposed struts) and that intraluminal masses (possible thrombus) were seen in malapposed BRS struts more often as compared with apposed struts (39% of ISA struts versus 2% apposed struts). 93, [113] [114] [115] Computational fluid dynamic analysis on stented/scaffolded segments demonstrated higher shear profiles in BRS compared with thin metallic DES, hence underlining the importance of imaging guidance, optimal expansion, and apposition during BRS implantation.
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Conclusion
To summarize, suboptimal stent implantation affects the local hemodynamic forces and can lead to unfavorable clinical outcomes. Regions of low ESS after PCI are colocated with neointima and neoatherosclerosis formation. High shear gradients and flow disturbances have been shown to increase the risk of thrombosis. Therefore, effort should be made to optimize stent deployment and stent/scaffold designs to ensure an optimal hemodynamic profile and reduce the risk of complications after PCI.
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